Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTRA1 | Q92743 | 9/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TACR1 | P25103 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21959744 | 1.00 | HTRA1 (0.56) | HTRA1KEAP1NFE2L2LMNAPOLB | |
| SCHEMBL18228666 | 0.96 | HTRA1 (0.58) | HTRA1KEAP1NFE2L2LMNAPOLB | |
| SCHEMBL21959121 | 0.96 | HTRA1 (0.58) | HTRA1KEAP1NFE2L2LMNAPOLB | |
| SCHEMBL18228819 | 0.83 | FPR2 (0.64) | HTRA1CA1CA2FDFT1MEN1 | |
| SCHEMBL21959742 | 0.83 | FPR2 (0.64) | HTRA1CA1CA2FDFT1MEN1 | |
| SCHEMBL18228919 | 0.80 | HTRA1 (0.59) | HTRA1TACR1FDFT1MEN1KMT2A | |
| SCHEMBL21960145 | 0.80 | HTRA1 (0.59) | HTRA1TACR1FDFT1MEN1KMT2A | |
| SCHEMBL7925442 | 0.79 | SLC6A2 (0.47) | KEAP1TACR1 | |
| SCHEMBL9444866 | 0.79 | SLC6A2 (0.47) | KEAP1TACR1 | |
| SCHEMBL28656153 | 0.79 | FPR2 (0.58) | HTRA1CA1CA2FDFT1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107531653-B | Novel difluoroketoamide derivatives | 豪夫迈·罗氏有限公司 | 2021-10-19 | — | — | CN | disclosed |
| EP-3294718-B1 | NEW DIFLUOROKETAMIDE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2020-04-29 | — | — | EP | disclosed |
| EP-3294718-B1 | NEW DIFLUOROKETAMIDE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2020-04-29 | — | — | EP | disclosed |
| US-10428108-B2 | Difluoroketamide derivatives | HOFFMANN-LA ROCHE INC. (US) | 2019-10-01 | — | — | US | disclosed |
| US-10428108-B2 | Difluoroketamide derivatives | HOFFMANN-LA ROCHE INC. (US) | 2019-10-01 | — | — | US | disclosed |
| EP-3294718-A1 | NEW DIFLUOROKETAMIDE DERIVATIVES | H. Hoffnabb-La Roche Ag (CH) | 2018-03-21 | — | — | EP | disclosed |
| US-20180057526-A1 | NEW DIFLUOROKETAMIDE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2018-03-01 | — | — | US | disclosed |
| US-20180057526-A1 | NEW DIFLUOROKETAMIDE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2018-03-01 | — | — | US | disclosed |
| US-20180057526-A1 | NEW DIFLUOROKETAMIDE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2018-03-01 | — | — | US | disclosed |
| CN-107531653-A | Novel difluoroketoamide derivatives | 豪夫迈·罗氏有限公司 | 2018-01-02 | — | — | CN | disclosed |
| WO-2016180751-A1 | NEW DIFLUOROKETAMIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2016-11-17 | — | — | WO | disclosed |
| WO-2016180751-A1 | NEW DIFLUOROKETAMIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2016-11-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180057526-A1 | NEW DIFLUOROKETAMIDE DERIVATIVES | PRMT9, CDK9, FLT3 | HTRA1 4463/4885KEAP1 3461/4885NFE2L2 3676/4885 |
| US-10428108-B2 | Difluoroketamide derivatives | PRMT9, CDK9, FLT3 | HTRA1 4586/4885KEAP1 2667/4885NFE2L2 2847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.